Workflow
盘龙药业: 独立董事候选人声明与承诺(王满仓)

Group 1 - The candidate Wang Mancang has been nominated as an independent director for the fifth board of Shaanxi Panlong Pharmaceutical Group Co., Ltd. by the controlling shareholder Xie Xiaolin [1] - The candidate confirms that there are no relationships that could affect his independence and meets the qualifications required by relevant laws and regulations [1][2] - The candidate has undergone qualification review by the nomination committee of the fourth board and has no conflicting interests with the nominator [1][2] Group 2 - The candidate affirms compliance with the requirements set forth by the China Securities Regulatory Commission and the Shenzhen Stock Exchange for independent directors [2][4] - The candidate has completed training and obtained relevant certification recognized by the stock exchange [2][5] - The candidate declares that he does not hold any position in the company or its subsidiaries, nor does he or his immediate family hold more than 1% of the company's shares [5][6][7] Group 3 - The candidate has no significant business dealings with the company or its controlling shareholders [7][8] - The candidate has not been subject to any criminal penalties or administrative sanctions related to securities in the past 36 months [7][8] - The candidate commits to fulfilling the responsibilities of an independent director diligently and independently, without influence from major shareholders or related parties [9]